Booz Allen Hamilton (BAH) Q2 FY2027: Mixed Results with Adjusted EPS Growth — Cautiously Optimistic: Calm Open (+0.1%) — Post-Earnings Analysis

Booz Allen Hamilton Holding Corporation (NYSE: BAH) reported its second quarter fiscal 2027 results, revealing a revenue decline but notable growth in adjusted earnings metrics. Specifically, revenue for the quarter was $2.8 billion, a decrease of $112 million or 3.9% year-over-year. However, adjusted diluted EPS increased by 18.1% to $1.76, reflecting strong operational execution and strategic investments.

Key Financial Metrics

• Revenue: $2.8 billion, down $112 million or -3.9% YoY
• Revenue Excluding Billable Expenses: $2.0 billion, down $15 million or -0.8% YoY
• Net Income: $181 million, up $6 million or +3.4% YoY
• Adjusted Net Income: $211 million, up $28 million or +15.3% YoY
• Adjusted EBITDA: $313 million, down $11 million or -3.4% YoY
• Adjusted EBITDA Margin on Revenue: 11.3%, up 10 basis points YoY
• Adjusted Diluted EPS: $1.76, up $0.27 or +18.1% YoY
• Free Cash Flow: $263 million, down $132 million or -33.4% YoY
• Total Backlog: $41 billion, up 1.9% YoY
• Quarterly Book-to-Bill Ratio: 1.5x

Analyst Opinion

This quarter presents a mixed bag for shareholders. While the decline in revenue is concerning, the increase in adjusted net income and adjusted diluted EPS indicates that Booz Allen is effectively managing its costs and enhancing profitability. The company's ability to raise its adjusted diluted EPS guidance for the fiscal year is a positive sign, suggesting confidence in future performance. However, the significant drop in free cash flow and the overall revenue decline could raise questions about the sustainability of growth moving forward.

Dividend and Capital Deployment

Booz Allen Hamilton declared a regular quarterly dividend of $0.59 per share, payable on December 4, 2026, to stockholders of record on November 12, 2026. The company also reported total capital deployment of $965 million during the quarter, which includes investments in strategic initiatives aimed at enhancing its cyber and defense technology offerings.

Guidance Update

The company has updated its fiscal 2027 guidance, now projecting:

• Revenue: $11.3 - $11.6 billion (previously $11.2 - $11.7 billion)
• Adjusted EBITDA: $1,260 - $1,290 million (previously $1,240 - $1,290 million)
• Adjusted Diluted EPS: $6.50 - $6.70 (previously $6.00 - $6.35)
• Free Cash Flow: $850 - $925 million (unchanged)

This upward revision in guidance, particularly for adjusted diluted EPS, reflects management's optimism about the company's operational execution and market positioning.

Forward Catalysts

Investors should closely monitor Booz Allen's performance in the upcoming quarters, particularly in relation to its investments in advanced technologies and the execution of its National Security portfolio. The company’s ability to maintain or improve its backlog and book-to-bill ratio will be critical indicators of future revenue growth. Additionally, any updates on strategic acquisitions or partnerships could serve as significant catalysts for stock performance.

In summary, while Booz Allen Hamilton's Q2 FY2027 results show some challenges, the growth in adjusted earnings metrics and the raised guidance provide a cautiously optimistic outlook for shareholders.

Note: The following tables contain amounts in millions.

Note: The following table contains amounts in millions.

Quarterly Earnings — Revenue vs. Estimate

Revenue vs. Estimate — 5 Quarters

EPS vs. Estimate — 5 Quarters

Analyst Ratings & Price Targets

Analysts have recently shown mixed but generally optimistic sentiment toward Booz Allen Hamilton (BAH), with two upgrades and one downgrade since late 2025. Truist upgraded BAH from Hold to Buy with an $85 target on October 8, 2026, while Stifel raised its rating to Buy with a bullish $110 target in May 2026. However, BofA Securities downgraded the stock to Underperform ($90) in October 2025, citing caution. New initiations from BNP Paribas Exane ($80, Neutral) and Wells Fargo ($85, Equal Weight) suggest a balanced outlook. The consensus price target, weighted toward recent upgrades, implies moderate upside from current levels, though dispersion in targets reflects divergent views on growth and valuation. The highest target ($110) suggests significant potential upside, while the lower end ($80–$85) aligns with a more cautious stance. Overall, the trend skews positive, with analysts increasingly favoring Buy ratings.

Technical Analysis — 90-Day Price Chart

Booz Allen Hamilton (BAH) trades at $77.87, firmly above its key moving averages (SMA20: $72.33, SMA50: $74.34), confirming a bullish near- and medium-term trend. The stock’s position above all three SMAs (20, 50, 200) suggests sustained upward momentum, with no recent bearish crossovers. The RSI(14) at 77.9 signals overbought conditions, indicating potential near-term consolidation or pullback risk. Volume at 2.07M shares exceeds the 20-day average of 1.72M, reinforcing bullish conviction. The stock trades near the upper end of its 52-week range ($59.05–$81.19), with the all-time high at $81.19 acting as immediate resistance, while the SMA50 ($74.34) and SMA20 ($72.33) provide dynamic support levels. The proximity to the 52-week high suggests limited overhead resistance but raises the likelihood of profit-taking near record levels.